Related references
Note: Only part of the references are listed.Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray
Daron J. Williams et al.
HUMAN PATHOLOGY (2009)
Triple-negative/basal-like breast cancer: review
Emad A. Rakha et al.
PATHOLOGY (2009)
The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
Jiyoung Rhee et al.
BMC CANCER (2008)
Clinical validation of a customized multiple signature microarray for breast cancer
Benita Kt Tan et al.
CLINICAL CANCER RESEARCH (2008)
Is acinic cell carcinoma a variant of secretory carcinoma?: A FISH study using ETV6 'split apart' probes
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2008)
Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters
Maureen Hong-Sing Chen et al.
MODERN PATHOLOGY (2008)
Clinicopathologic and Prognostic Characteristics of Triple-Negative Breast Cancer
Xing-song Tian et al.
ONKOLOGIE (2008)
The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races
Junichi Kurebayashi et al.
BREAST (2007)
Demystifying basal-like breast carcinomas
L. Da Silva et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients - A single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results Database
Gloria J. Morris et al.
CANCER (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
Marc Tischkowitz et al.
BMC CANCER (2007)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
Prognostic markers in triple-negative breast cancer
Emad A. Rakha et al.
CANCER (2007)
Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival
Laura G. Fulford et al.
BREAST CANCER RESEARCH (2007)
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer
Bruce G. Haffty et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
CA Livasy et al.
MODERN PATHOLOGY (2006)
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342
Lyndsay N. Harris et al.
BREAST CANCER RESEARCH (2006)
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients
Stefano Calza et al.
BREAST CANCER RESEARCH (2006)
Molecular classification and molecular forecasting of breast cancer: Ready for clinical application?
JD Brenton et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
C Sotiriou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome
M van de Rijn et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
